Aveo teams with Bristol Myers after surprise FDA approval; CalciMedica lines up $21M raise to advance Covid-19 candidate
Aveo Oncology’s newly approved drug doesn’t extend lives, but hey, maybe it will when combined with Opdivo?
Aveo announced Friday that it was launching a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
